Andrea Newkirk
Stock Analyst at Goldman Sachs
(2.81)
# 1,930
Out of 5,041 analysts
5
Total ratings
100%
Success rate
20.75%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $22.52 | -15.63% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $54.48 | +33.99% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $29.80 | +44.30% | 1 | Jul 15, 2025 | |
| ETNB 89bio | Initiates: Neutral | $11 | $14.79 | -25.63% | 1 | Mar 14, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $22.52
Upside: -15.63%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $54.48
Upside: +33.99%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $29.80
Upside: +44.30%
89bio
Mar 14, 2025
Initiates: Neutral
Price Target: $11
Current: $14.79
Upside: -25.63%